Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M964Revenue $M114Net Margin (%)-0.8Altman Z-Score11.1
Enterprise Value $M854EPS $-0.3Operating Margin %-1.5Piotroski F-Score4
P/E(ttm)--Beneish M-Score0.8Pre-tax Margin (%)0.6Higher ROA y-yN
Price/Book7.210-y EBITDA Growth Rate %--Quick Ratio4.0Cash flow > EarningsY
Price/Sales7.85-y EBITDA Growth Rate %--Current Ratio4.2Lower Leverage y-yN
Price/Free Cash Flow34.3y-y EBITDA Growth Rate %-81.8ROA % (ttm)-0.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-0.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M21.0ROIC % (ttm)-15.0Gross Margin Increase y-yY

Gurus Latest Trades with HPTX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HPTXMario Gabelli 2015-03-31 Buy 0.04%$23.34 - $45.98
($29.92)
$ 45.9954%New holding169,000
HPTXJoel Greenblatt 2015-03-31 Sold Out -0.0024%$23.34 - $45.98
($29.92)
$ 45.9954%Sold Out0
HPTXJoel Greenblatt 2014-12-31 Reduce$20.4 - $25.23
($22.43)
$ 45.99105%Reduce 30.66%12,557
HPTXJoel Greenblatt 2014-09-30 Buy $21.96 - $27.64
($24.83)
$ 45.9985%New holding18,109
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HPTX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


HPTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Nash Christine ASVP & Chief Commercial Officer 2015-03-17Sell10,000$37.5622.44view
Nash Christine ASVP & Chief Commercial Officer 2015-03-10Sell9,900$29.6355.21view
Nash Christine ASVP & Chief Commercial Officer 2015-03-10Sell10,000$35.0831.1view
Scharschmidt Bruce FrederickSVP & Chief Medical Officer 2015-02-27Sell29,800$29.8953.86view
Nash Christine ASVP & Chief Commercial Officer 2015-01-20Sell5,000$24.8285.29view
Scharschmidt Bruce FrederickSVP & Chief Medical Officer 2014-07-02Sell200$2864.25view
KOLLURI KRISHNA KITTU10% Owner 2014-06-06Sell120$27.1969.14view
BARRIS PETER J10% Owner 2014-06-06Sell1,134$26.970.97view
BASKETT FOREST10% Owner 2014-06-06Sell1,377$26.970.97view
BARRETT M JAMES10% Owner 2014-06-06Sell1,430$26.8871.09view

Quarterly/Annual Reports about HPTX:

    News about HPTX:

    Articles On GuruFocus.com

    More From Other Websites
    Horizon Pharma Net Rises 62%, Sales Double, Guidance Lifted May 08 2015
    HYPERION THERAPEUTICS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... May 07 2015
    What's in Store for Horizon Pharma (HZNP) in Q1 Earnings? - Analyst Blog May 07 2015
    Horizon Pharma plc Completes Acquisition of Hyperion Therapeutics, Inc. May 07 2015
    Horizon Pharma plc Completes Acquisition of Hyperion Therapeutics, Inc. May 07 2015
    Horizon Pharma plc Announces Results of Tender Offer May 07 2015
    Horizon Pharma plc Announces Results of Tender Offer May 07 2015
    HYPERION THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report May 06 2015
    Horizon Pharma plc Announces Waiver of Financing Proceeds Condition Apr 30 2015
    Horizon Pharma plc Announces Waiver of Financing Proceeds Condition Apr 30 2015
    Horizon Pharma plc Announces Expiration of HSR Waiting Period for Proposed Hyperion Therapeutics,... Apr 29 2015
    Horizon Pharma plc Announces Expiration of HSR Waiting Period for Proposed Hyperion Therapeutics,... Apr 29 2015
    US HY CLOSE-High-yield week tally goes over US$10bn Apr 24 2015
    US HY CLOSE-Three high-yield issuers raise US$1.815bn Apr 23 2015
    Great Point Partners Trims Its Stake In Alcobra Ltd (ADHD) Apr 22 2015
    HYPERION THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Hyperion... Apr 20 2015
    Horizon Pharma PLC -- Moody's assigns B2 Corporate Family Rating to Horizon Pharma Apr 20 2015
    IPO Summit Materials A Bright Spot In Ugly Session Apr 17 2015
    HPTX INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of... Apr 13 2015
    SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of... Apr 10 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK